Colon Cancer

More Positive Results For Everist Genomics' OncoDefender-CRCEverist Genomics, a developer of personalized medicine, announced the publication of positive results from an international validation study which demonstrated that the OncoDefender-CRC colorectal cancer test result is a significant independent predictor of recurrence in node-negative, invasive colorectal cancer patients.
New Cancer Recurrence Test From Ann Arbor Firm
UM Cancer Center Gets $10.7M Fed GrantThe University of Michigan Comprehensive Cancer Center has received a five-year $10.7 million grant from the National Cancer Institute to study colorectal and pancreatic cancer.
UM Study Finds Surgery Complicaitons Lead To Chemo Delay
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen